Recent Events
-
15 March 2019Neugierde fördern, Fakten vermitteln und Fragen beantworten: Der Exzellenzcluster REBIRTH lädt im ...
Press releases
Abitur und dann? Die MHH und Partnerinstitutionen bieten das Freiwillige Jahr in der Wissenschaft an
Informationsveranstaltung am 18. Februar um 16 Uhr in der Hochschule Die Medizinische Hochschule Hannover (MHH) bietet ab September zum neunten Mal ein Freiwilliges Jahr in der Wissenschaft (FWJ) für Abiturientinnen und... [more]
Neues Blut dank neuer Technik
Die Herstellung von Blutzellen schreitet voran / MHH-Forscher legen Grundstein für neue Therapie zur Bekämpfung von Infektionen / Veröffentlichung in Nature Communications Blut ist ein ganz besonderer Saft: Es erfüllt... [more]
REBIRTH researchers identify potential drug to treat rare condition
A substance has been identified that alleviates symptoms of a rare vascular disease called cerebral cavernous malformation (CCM). It was found thanks to comprehensive analysis – using a mouse model – within a consortium headed by... [more]
System for transporting donor lungs approved in USA following trial
In a clinical trial called INSPIRE, a large international team of investigators led by physicians at Hannover Medical School (MHH) has shown that the transport and storage of donor lungs using the Organ Care System (OCS) –... [more]
Hannoversche Forscher wollen „unsichtbare“ Organe schaffen
Für Menschen, die ein Spenderorgan transplantiert bekommen, beginnt ein neuer Lebensabschnitt mit einem gesunden Organ. Doch sie leben auch mit dem Risiko, dass ihr Körper das gespendete Organ wieder abstößt. Das passiert... [more]
Like leaves in a stream: researchers explore the biomechanics of heart valve development
Over the course of an 80-year life, the human heart pumps more than 200 million litres of blood through the body. This impressive feat is crucially dependent on the formation of cardiac valves, which are absent in the early... [more]
An exciting prospect: patients cured by their own cells?
Altering patients’ own cells so they can replace defective or absent cells – researchers at Hannover Medical School (MHH) have moved a step closer to achieving this. The scientists are investigating hereditary pulmonary alveolar... [more]
Organ Care System: MHH physicians treat diseased lung outside the body
The growing resistance of pathogens to antibiotics means that, in an increasing number of cases, doctors are out of alternative treatment options for severe pneumonia. Medics at Hannover Medical School (MHH) have, for the first... [more]
Hilfiker-Kleiner joins prestigious academic body
Professor Denise Hilfiker-Kleiner, dean of research at Hannover Medical School (MHH) and leader of a REBIRTH unit, became a new member of Germany’s Council of Science and Humanities (WR) with effect from 1 February 2018. Federal... [more]
Gene therapy for rare blood condition
Scientists at Hannover Medical School (MHH) have achieved a first: they have developed a successful cell and gene therapy for a genetic infectious disease. It appears to be a promising treatment for a rare and life-threatening... [more]
How are artificial lungs implanted?
For people with certain serious lung conditions, a lung transplant is the only curative treatment option. However, only a small proportion of patients can receive this treatment, as there are fewer and fewer organ donors... [more]
Reducing scar size after heart attack
Scientists at Hannover Medical School (MHH) have discovered a previously unknown growth factor that improves cardiac muscle healing after a heart attack, so that even a major infarction results in only a small scar. They... [more]
Innovation is the basis for new fibrosis treatment
It is often the case that one only realizes how important something is when it stops working. Researchers at Hannover Medical School (MHH) have capitalized on this fact: using a new method, they succeeded in specifically... [more]
Cluster of Excellence REBIRTH took the first hurdle within the German Strategy of Excellence
The Cluster of Excellence REBIRTH took the first hurdle within the Excellence Strategy of the federal government and states: The Cluster is invited to submit the full proposal for the new concept REBIRTHT4S (From Regenerative... [more]
Spinoff company receives a boost worth millions
“We use what are known as non-coding ribonucleic acids (RNAs) to diagnose and treat heart conditions such as cardiac insufficiency,“ says Professor Thomas Thum, founder of a Hannover Medical School (MHH) spinoff company called... [more]